Abiopharma

Director BALBIRNIE BRIAN R 🟢 acquired 3.4K shares of ACCESS Newswire Inc. (ACCS) at $7.54 Transaction Date: Mar 25, 2026 | Filing ID: 002259

(30% Negative) APTEVO THERAPEUTICS INC. (APVO) Reports Q1 2026 Financial Results

P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results

📋 JESSICA WOELFEL (Officer) plans to sell 3K shares of ORMAT TECHNOLOGIES, INC. (at $110.39 each, total $294K) Filed: Mar 26, 2026 | ID: 003017

Unity Releases Preliminary First Quarter Results Exceeding Guidance; Will Enhance Growth and Profitability by Exiting Non-Strategic Ad Businesses

Bloom Energy Appoints Simon Edwards as Chief Financial Officer

Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date

MP Materials to Participate in Deutsche Bank Virtual Investor Event

CROWN HOLDINGS, INC. APPOINTS DR. JOHN M. ROST EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER - ASIA PACIFIC AND TRANSIT PACKAGING

Dominos® Announces Q1 2026 Earnings Webcast

BGC Group Updates its Outlook for the First Quarter of 2026

Xanadu Quantum Technologies Limited Announces Closing of Business Combination with Crane Harbor Acquisition Corp. and Xanadu Quantum Technologies Inc.

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

SKYX Reports Another Record Quarter with Revenue of $25 Million in Q-4 Demonstrating 8 Consecutive Quarters of Year Over Year Growth with Annual Record Revenue of $92 Million in 2025 Compared to $86 Million in 2024 as it Continues to Grow its Market Penetration

SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update